Leukemia, Published online: 11 November 2026; doi:10.1038/s41375-026-03173-0 Mediator kinase inhibition exposes a transcriptional vulnerability and synergizes with venetoclax in AML
Camille Aitchedji, Céline Moison, Simon Fortier, Rodrigo Mendoza-Sanchez, Deanne Gracias, Jean-François Spinella et al. Mediator kinase inhibition exposes a transcriptional vulnerability and synergizes with venetoclax in AML. // Leukemia. – 2026. – DOI: 10.1038/s41375-026-03173-0. – URL: https://www.nature.com/articles/s41375-026-03173-0
Camille Aitchedji, Céline Moison, Simon Fortier, Rodrigo Mendoza-Sanchez, Deanne Gracias, Jean-François Spinella, Bounkham Thavonekham, Tara MacRae, Nadine Mayotte, Mélanie Fréchette, Valérie Blouin-Chagnon, Koryne Léveillé, Jalila Chagraoui, Réjean Ruel, Josée Hébert, Anne Marinier, & Guy Sauvageau (2026). Mediator kinase inhibition exposes a transcriptional vulnerability and synergizes with venetoclax in AML. Leukemia. https://doi.org/10.1038/s41375-026-03173-0
Camille Aitchedji, et al. “Mediator kinase inhibition exposes a transcriptional vulnerability and synergizes with venetoclax in AML.” Leukemia, 2026. doi:10.1038/s41375-026-03173-0.
@article{Aitchedji2026,
title = {Mediator kinase inhibition exposes a transcriptional vulnerability and synergizes with venetoclax in AML},
author = {Aitchedji, Camille and Moison, Céline and Fortier, Simon and Mendoza-Sanchez, Rodrigo and Gracias, Deanne and Spinella, Jean-François and Thavonekham, Bounkham and MacRae, Tara and Mayotte, Nadine and Fréchette, Mélanie and Blouin-Chagnon, Valérie and Léveillé, Koryne and Chagraoui, Jalila and Ruel, Réjean and Hébert, Josée and Marinier, Anne and Sauvageau, Guy},
journal = {Leukemia},
year = {2026},
doi = {10.1038/s41375-026-03173-0},
url = {https://www.nature.com/articles/s41375-026-03173-0}
}